<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2018-1-78-84</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-813</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Наследственные периодические лихорадки в практике взрослого ревматолога</article-title><trans-title-group xml:lang="en"><trans-title>Hereditary periodic fever syndromes in adult rheumatology practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Желябина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhelyabina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеев</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseev</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><email xlink:type="simple">elicmax@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чикина</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chikina</surname><given-names>M. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>02</day><month>04</month><year>2018</year></pub-date><volume>12</volume><issue>1</issue><fpage>78</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Желябина О.В., Елисеев М.С., Чикина М.Н., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Желябина О.В., Елисеев М.С., Чикина М.Н.</copyright-holder><copyright-holder xml:lang="en">Zhelyabina O.V., Eliseev M.S., Chikina M.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/813">https://mrj.ima-press.net/mrj/article/view/813</self-uri><abstract><p>Аутовоспалительные заболевания (АВЗ) – гетерогенная группа редких генетически детерминированных, наследственно обусловленных состояний, характеризующихся  непровоцируемыми приступами воспаления, манифестирующими рецидивирующей лихорадкой и клинической симптоматикой, напоминающей ревматические проявления, при  отсутствии аутоиммунных или инфекционных причин. Распространенность в популяции  наследственных АВЗ имеет тенденцию к увеличению. Перечень АВЗ довольно широк и  включает различные группы заболеваний, в том числе те, с которыми приходится  сталкиваться не только педиатру, но и специалисту взрослой ревматологической службы.  Наследственные АВЗ мало известны практическим врачам, поэтому диагноз нередко  ставится с опозданием. Однако благодаря внедрению в клиническую практику новых  методов диагностики, в первую очередь генетических, а также лекарственной терапии в  выявлении и лечении этих заболеваний наметился отчетливый прогресс, что позволяет  изменить отдаленный прогноз при АВЗ и вызывает все больший интерес к ним не только у  педиатров, генетиков, но и у ревматологов, врачей общей практики.</p></abstract><trans-abstract xml:lang="en"><p>Autoinflammatory diseases (AIDs) are a heterogeneous group of rare genetically determined, hereditary conditions characterized by unprovoked inflammatory episodes that are manifested by recurrent  fever and clinical symptoms reminiscent of rheumatic manifestations in the absence of autoimmune or infectious causes. The prevalence of hereditary AIDs in the population tends to increase. The list of AIDs is quite wide and includes various groups of diseases, including  those faced by not only a pediatrician, but also by an adult  rheumatology specialist. Practitioners do not know much about  hereditary AIDs, so the latter are often diagnosed late. However, due to the clinical introduction of new diagnostic techniques, primarily  genetic ones, and drug therapy in the detection and treatment of  these diseases, there has been clear progress, which makes it possible to change long-term prognosis in AIDs and to arouse increasing interest in the diseases not only among pediatricians, geneticists, but also among rheumatologists and general practitioners.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>аутовоспалительные заболевания</kwd><kwd>периодические лихорадки</kwd><kwd>семейная средиземноморская лихорадка</kwd><kwd>интерлейкин 1.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>autoinflammatory diseases</kwd><kwd>periodic fever syndromes</kwd><kwd>familial Mediterranean fever</kwd><kwd>interleukin-1.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fietta P. Autoinflammatory disease: thehereditary periodic fever syndromes. Acta Biomed. 2004 Aug;75(2):92-9.</mixed-citation><mixed-citation xml:lang="en">Fietta P. Autoinflammatory disease: thehereditary periodic fever syndromes. Acta Biomed. 2004 Aug;75(2):92-9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Федоров ЕС, Салугина СО, Кузьмина НН. Аутовоспалительные синдромы: что необходимо знать ревматологу. Современная ревматология. 2012;6(2):49-59. [Fedorov ES, Salugina SO, Kuz'mina NN. Autoinflammatory syndromes: What a rheumatologist should know. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2012;6(2): 49-59. (In Russ.)]. doi: 10.14412/1996-7012-2012-728.</mixed-citation><mixed-citation xml:lang="en">Федоров ЕС, Салугина СО, Кузьмина НН. Аутовоспалительные синдромы: что необходимо знать ревматологу. Современная ревматология. 2012;6(2):49-59. [Fedorov ES, Salugina SO, Kuz'mina NN. Autoinflammatory syndromes: What a rheumatologist should know. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2012;6(2): 49-59. (In Russ.)]. doi: 10.14412/1996-7012-2012-728.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Simon A, van der Meer JW. Patogenesis of familial periodic fever syndromes or hereditary inflammatory syndromes. Am J Physiol Regul Integr Comp Physiol. 2007 Jan; 292(1):R86-98. Epub 2006 Aug 24.</mixed-citation><mixed-citation xml:lang="en">Simon A, van der Meer JW. Patogenesis of familial periodic fever syndromes or hereditary inflammatory syndromes. Am J Physiol Regul Integr Comp Physiol. 2007 Jan; 292(1):R86-98. Epub 2006 Aug 24.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012 Jul;71(7):1177-82. doi: 10.1136/annrheumdis-2011-200549. Epub 2012 Feb 29.</mixed-citation><mixed-citation xml:lang="en">Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012 Jul;71(7):1177-82. doi: 10.1136/annrheumdis-2011-200549. Epub 2012 Feb 29.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gattorno M, Tassi S, Carta S, et al. Pattern of interleukin-1b secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 2007 Sep;56(9):3138-48. doi: 10.1002/art.22842</mixed-citation><mixed-citation xml:lang="en">Gattorno M, Tassi S, Carta S, et al. Pattern of interleukin-1b secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 2007 Sep;56(9):3138-48. doi: 10.1002/art.22842</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ, Елисеев МС. Роль интерлейкина 1 в развитии заболеваний человека. Научно-практическая ревматология. 2016;54(1):60-77. [Nasonov EL, Eliseev MS. Role of interleukin 1 in the development of human diseases. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2016;54(1):60-77. (In Russ.)]. doi: 10.14412/1995-4484-2016-60-77</mixed-citation><mixed-citation xml:lang="en">Насонов ЕЛ, Елисеев МС. Роль интерлейкина 1 в развитии заболеваний человека. Научно-практическая ревматология. 2016;54(1):60-77. [Nasonov EL, Eliseev MS. Role of interleukin 1 in the development of human diseases. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2016;54(1):60-77. (In Russ.)]. doi: 10.14412/1995-4484-2016-60-77</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol. 2011 May;41(5):1203-17. doi: 10.1002/eji.201141550.</mixed-citation><mixed-citation xml:lang="en">Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol. 2011 May;41(5):1203-17. doi: 10.1002/eji.201141550.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mensa-Vilaro A, Teresa Bosque M, Magri G, et al. Late onset cryopyrin-associated periodic syndrome due to myeloidrestricted somatic NLRP3 mosaicism. Arthritis Rheumatol. 2016 Dec;68(12):3035- 3041. doi: 10.1002/art.39770.</mixed-citation><mixed-citation xml:lang="en">Mensa-Vilaro A, Teresa Bosque M, Magri G, et al. Late onset cryopyrin-associated periodic syndrome due to myeloidrestricted somatic NLRP3 mosaicism. Arthritis Rheumatol. 2016 Dec;68(12):3035- 3041. doi: 10.1002/art.39770.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Barron K, Athreya B, Kastner D. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Cassidy JT, editor. Textbook of pediatric rheumatology. 6th ed. Elsevier Saunders; 2011. P. 642-60.</mixed-citation><mixed-citation xml:lang="en">Barron K, Athreya B, Kastner D. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Cassidy JT, editor. Textbook of pediatric rheumatology. 6th ed. Elsevier Saunders; 2011. P. 642-60.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kile RL, Rusk HA. A case of cold urticaria with unusual family history. JAMA. 1940;114:1067-8.</mixed-citation><mixed-citation xml:lang="en">Kile RL, Rusk HA. A case of cold urticaria with unusual family history. JAMA. 1940;114:1067-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yamauchi A, Iwata H, Ohnishi H, et al. Interleukin-17 expression in the urticarial rash of familial cold autoinflammatory syndrome: a case report. Br J Dermatol. 2010 Dec;163(6):1351-3. doi: 10.1111/j.1365-2133.2010.09978.x. Epub 2010 Nov 4.</mixed-citation><mixed-citation xml:lang="en">Yamauchi A, Iwata H, Ohnishi H, et al. Interleukin-17 expression in the urticarial rash of familial cold autoinflammatory syndrome: a case report. Br J Dermatol. 2010 Dec;163(6):1351-3. doi: 10.1111/j.1365-2133.2010.09978.x. Epub 2010 Nov 4.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Espandar L, Boehlke CS, Kelly MP. First report of keratitis in familial old autoinflammatory syndrome. Can J Ophthalmol. 2014 Jun;49(3):304-6. doi: 10.1016/j.jcjo.2014.01.007.</mixed-citation><mixed-citation xml:lang="en">Espandar L, Boehlke CS, Kelly MP. First report of keratitis in familial old autoinflammatory syndrome. Can J Ophthalmol. 2014 Jun;49(3):304-6. doi: 10.1016/j.jcjo.2014.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gerbig AW, Dahinden CA, Mullis P, Hunziker T. Circadian elevation of IL-6 levels in Muckle-Wells syndrome: a disorder of the neuro-immune axis? QJM. 1998 Jul;91(7): 489-92.</mixed-citation><mixed-citation xml:lang="en">Gerbig AW, Dahinden CA, Mullis P, Hunziker T. Circadian elevation of IL-6 levels in Muckle-Wells syndrome: a disorder of the neuro-immune axis? QJM. 1998 Jul;91(7): 489-92.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dode C, Le Du N, Cuisset L, et al. New mutations of CIAS that are responsible for Muckle- Wells syndrome and familial cold urticaria: a novel mutation underlies both syndrome. Am J Hum Genet. 2002 Jun;70(6): 1498-506. Epub 2002 Apr 25.</mixed-citation><mixed-citation xml:lang="en">Dode C, Le Du N, Cuisset L, et al. New mutations of CIAS that are responsible for Muckle- Wells syndrome and familial cold urticaria: a novel mutation underlies both syndrome. Am J Hum Genet. 2002 Jun;70(6): 1498-506. Epub 2002 Apr 25.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Салугина СО, Федоров ЕС, Кузьмина НН. Современные подходы к диагностике, лечению и мониторингу пациентов с криопирин-ассоциированными периодическими синдромами (CAPS). Современная ревматология. 2016;10(2):4-11. [Salugina SO, Fedorov ES, Kuz'mina NN. Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrinassociated periodic syndromes (CAPS). Sovremennaya revmatologiya = Modern Rheumatology Journal. 2016;10(2):4-11. (In Russ.)]. DOI:10.14412/1996-7012-2016-2-4-11.</mixed-citation><mixed-citation xml:lang="en">Салугина СО, Федоров ЕС, Кузьмина НН. Современные подходы к диагностике, лечению и мониторингу пациентов с криопирин-ассоциированными периодическими синдромами (CAPS). Современная ревматология. 2016;10(2):4-11. [Salugina SO, Fedorov ES, Kuz'mina NN. Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrinassociated periodic syndromes (CAPS). Sovremennaya revmatologiya = Modern Rheumatology Journal. 2016;10(2):4-11. (In Russ.)]. DOI:10.14412/1996-7012-2016-2-4-11.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kuemmerle-Deschner JB, Koitschev A, Ummenhofer K, et al. Hearing loss in Muckle- Wells syndrome. Arthritis Rheum. 2013 Mar;65(3):824-31. doi:10.1002/art.37810.</mixed-citation><mixed-citation xml:lang="en">Kuemmerle-Deschner JB, Koitschev A, Ummenhofer K, et al. Hearing loss in Muckle- Wells syndrome. Arthritis Rheum. 2013 Mar;65(3):824-31. doi:10.1002/art.37810.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lieberman A, Grossman ME, Silvers DN. Muckle-Wells syndrome: case report and review of cutaneous pathology. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):290-1.</mixed-citation><mixed-citation xml:lang="en">Lieberman A, Grossman ME, Silvers DN. Muckle-Wells syndrome: case report and review of cutaneous pathology. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):290-1.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Goldbach-Mansky R, Daily NJ, Canna SW, et al. Neonatal-Onset Mutisystem Inflammatory Disease Responsive to Interleukine-1 Inhibition. N Engl J Med. 2006 Aug 10;355(6):581-92.</mixed-citation><mixed-citation xml:lang="en">Goldbach-Mansky R, Daily NJ, Canna SW, et al. Neonatal-Onset Mutisystem Inflammatory Disease Responsive to Interleukine-1 Inhibition. N Engl J Med. 2006 Aug 10;355(6):581-92.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Goldbach-Mansky R, Shroff SD, Wilson M, et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 2008 Aug;58(8): 2432-42. doi: 10.1002/art.23620.</mixed-citation><mixed-citation xml:lang="en">Goldbach-Mansky R, Shroff SD, Wilson M, et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 2008 Aug;58(8): 2432-42. doi: 10.1002/art.23620.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lachmann H, Kone-Paut I, Kuemmerle-Deschner GB, et al. for the Canakinumab in CAPS Study Group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009 Jun 4;360(23):2416-25. doi: 10.1056/NEJMoa0810787.</mixed-citation><mixed-citation xml:lang="en">Lachmann H, Kone-Paut I, Kuemmerle-Deschner GB, et al. for the Canakinumab in CAPS Study Group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009 Jun 4;360(23):2416-25. doi: 10.1056/NEJMoa0810787.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Simon A, Drewe E, van der Meer JW. Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome. Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome. Clin Pharmacol Ther. 2004 May;75(5):476-83.</mixed-citation><mixed-citation xml:lang="en">Simon A, Drewe E, van der Meer JW. Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome. Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome. Clin Pharmacol Ther. 2004 May;75(5):476-83.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinemia D and periodic fever: a new syndrome. Lancet. 1984 May 19; 1(8386):1087-90.</mixed-citation><mixed-citation xml:lang="en">Van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinemia D and periodic fever: a new syndrome. Lancet. 1984 May 19; 1(8386):1087-90.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Haas D, Hoffmans GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006 Apr 26;1:13.</mixed-citation><mixed-citation xml:lang="en">Haas D, Hoffmans GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006 Apr 26;1:13.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Arostegui JI, Anton J, Calvo I, et al. Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome. Arthritis Rheumatol. 2017 Aug;69(8):1679-1688. doi: 10.1002/art.40146. Epub 2017 Jul 5.</mixed-citation><mixed-citation xml:lang="en">Arostegui JI, Anton J, Calvo I, et al. Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome. Arthritis Rheumatol. 2017 Aug;69(8):1679-1688. doi: 10.1002/art.40146. Epub 2017 Jul 5.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford). 2004 Apr;43(4):410-5. Epub 2004 Feb 24.</mixed-citation><mixed-citation xml:lang="en">Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford). 2004 Apr;43(4):410-5. Epub 2004 Feb 24.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kuijk LM, Hoffman HL, Neven B, Frenkel J. Episodic autoinflammatory disorders in children. In: Cimas R, Lehman T, editors. Handbook of Systemic Autoimmune Disease. Vol. 6 Pediatrcs in Systemic Autoimmune Disease. Elselvier; 2008. P. 119-35.</mixed-citation><mixed-citation xml:lang="en">Kuijk LM, Hoffman HL, Neven B, Frenkel J. Episodic autoinflammatory disorders in children. In: Cimas R, Lehman T, editors. Handbook of Systemic Autoimmune Disease. Vol. 6 Pediatrcs in Systemic Autoimmune Disease. Elselvier; 2008. P. 119-35.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kusuhara K, Nomura A, Nakao F, Hara T. Tumor necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur J Pediatr. 2004 Jan;163(1):30-2. Epub 2003 Nov 11.</mixed-citation><mixed-citation xml:lang="en">Kusuhara K, Nomura A, Nakao F, Hara T. Tumor necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur J Pediatr. 2004 Jan;163(1):30-2. Epub 2003 Nov 11.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Drenth G, van der Meer JW. Hereditary Periodic fever. N Engl J Med. 2001 Dec 13; І345(24):1748-57.</mixed-citation><mixed-citation xml:lang="en">Drenth G, van der Meer JW. Hereditary Periodic fever. N Engl J Med. 2001 Dec 13; І345(24):1748-57.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gattorno M, Obici L, Cattalini M, et al. Canakinumab treatment for patients with active recurrent or chronic TNF receptorassociated periodic syndrome (TRAPS an op label, phase II study. Ann Rheum Dis. 2017 Jan; 76(1):173-178. doi: 10.1136/annrheumdis-2015-209031. Epub 2016 Jun 7.</mixed-citation><mixed-citation xml:lang="en">Gattorno M, Obici L, Cattalini M, et al. Canakinumab treatment for patients with active recurrent or chronic TNF receptorassociated periodic syndrome (TRAPS an op label, phase II study. Ann Rheum Dis. 2017 Jan; 76(1):173-178. doi: 10.1136/annrheumdis-2015-209031. Epub 2016 Jun 7.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">La Torre F, Caparello MC, Cimaz R. Canakinumab for the treatment of TNF-receptor associated periodic syndrome. Expert Rev Clin Immunol. 2017 Jun;13(6):513-523. doi: 10.1080/1744666X.2017.1324783.</mixed-citation><mixed-citation xml:lang="en">La Torre F, Caparello MC, Cimaz R. Canakinumab for the treatment of TNF-receptor associated periodic syndrome. Expert Rev Clin Immunol. 2017 Jun;13(6):513-523. doi: 10.1080/1744666X.2017.1324783.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Drenth G, van der Meer JW. Hereditary Periodic fever. N Engl J Med. 2001 Dec 13; 345(24):1748-57.</mixed-citation><mixed-citation xml:lang="en">Drenth G, van der Meer JW. Hereditary Periodic fever. N Engl J Med. 2001 Dec 13; 345(24):1748-57.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Федоров ЕС, Салугина СО, Кузьмина НН. Семейная средиземноморская лихорадка (периодическая болезнь): современный взгляд на проблему. Современная ревматология. 2013;7(1):24-30. [Fedorov ES, Salugina SO, Kuz'mina NN. Familial Mediterranean fever (a periodic disease): The present-day view of the problem. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2013;7(1):24-30. (In Russ.)]. doi: 10.14412/1996-7012-2013-2363.</mixed-citation><mixed-citation xml:lang="en">Федоров ЕС, Салугина СО, Кузьмина НН. Семейная средиземноморская лихорадка (периодическая болезнь): современный взгляд на проблему. Современная ревматология. 2013;7(1):24-30. [Fedorov ES, Salugina SO, Kuz'mina NN. Familial Mediterranean fever (a periodic disease): The present-day view of the problem. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2013;7(1):24-30. (In Russ.)]. doi: 10.14412/1996-7012-2013-2363.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнян ВМ, Акопян ГС. Периодическая болезнь (этиопатогенетические и клинические аспекты). Москва: МИА; 2000. [Arutyunyan VM, Akopyan GS. Periodicheskaya bolezn' (etiopatogeneticheskie i klinicheskie aspekty) [Periodic disease (etiopathogenetic and clinical aspects)]. Moscow: MIA; 2000.]</mixed-citation><mixed-citation xml:lang="en">Арутюнян ВМ, Акопян ГС. Периодическая болезнь (этиопатогенетические и клинические аспекты). Москва: МИА; 2000. [Arutyunyan VM, Akopyan GS. Periodicheskaya bolezn' (etiopatogeneticheskie i klinicheskie aspekty) [Periodic disease (etiopathogenetic and clinical aspects)]. Moscow: MIA; 2000.]</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kalinich T, Haffer D, Niehues T, et al. Colchicine Use in Children and Adolescents With Familial Mediterranean Fever. Literature Review and Consensus Statement. Pediatrics. 2007 Feb;119(2):e474-83. Epub 2007 Jan 22.</mixed-citation><mixed-citation xml:lang="en">Kalinich T, Haffer D, Niehues T, et al. Colchicine Use in Children and Adolescents With Familial Mediterranean Fever. Literature Review and Consensus Statement. Pediatrics. 2007 Feb;119(2):e474-83. Epub 2007 Jan 22.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Алекберова ЗС, Барскова ВГ. Колхицин в ревматологии – вчера и сегодня. Будет ли завтра? Современная ревматология. 2010;4(2):25-9. [Alekberova ZS, Barskova VG. Colchicine in rheumatology: yesterday and today. Will there be tomorrow? Sovremennaya revmatologiya = Modern Rheumatology Journal. 2010;4(2):25-9. (In Russ.)]. DOI:10.14412/1996-7012-2010-598.</mixed-citation><mixed-citation xml:lang="en">Алекберова ЗС, Барскова ВГ. Колхицин в ревматологии – вчера и сегодня. Будет ли завтра? Современная ревматология. 2010;4(2):25-9. [Alekberova ZS, Barskova VG. Colchicine in rheumatology: yesterday and today. Will there be tomorrow? Sovremennaya revmatologiya = Modern Rheumatology Journal. 2010;4(2):25-9. (In Russ.)]. DOI:10.14412/1996-7012-2010-598.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2002 Aug;161(8):449-54. Epub 2002 Jun 28.</mixed-citation><mixed-citation xml:lang="en">Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2002 Aug;161(8):449-54. Epub 2002 Jun 28.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Frenkel J, Kuijk L, Hofhuis W, et al. Anakinra in colchicin resistant Familial Mediterranean Fever in 14th European Paediatric Rheumatology Congress. Sept. 5-9, 2007. Istanbul. Abstr book:252.</mixed-citation><mixed-citation xml:lang="en">Frenkel J, Kuijk L, Hofhuis W, et al. Anakinra in colchicin resistant Familial Mediterranean Fever in 14th European Paediatric Rheumatology Congress. Sept. 5-9, 2007. Istanbul. Abstr book:252.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Metyas S, Arkfeld DG, Forrester DM, Ehresmann GR. Infliximab treatment of Familial Mediterranean Fever and its effect to secondary AA amyloidosis. J Clin Rheumatol. 2004 Jun;10(3):134-7.</mixed-citation><mixed-citation xml:lang="en">Metyas S, Arkfeld DG, Forrester DM, Ehresmann GR. Infliximab treatment of Familial Mediterranean Fever and its effect to secondary AA amyloidosis. J Clin Rheumatol. 2004 Jun;10(3):134-7.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Аствацатрян ВА, Торосян ЕХ. Периодическая болезнь у детей. Ереван: Айастан; 1989. [Astvatsatryan VA, Torosyan EKh. Periodicheskaya bolezn' u detei [Periodic disease in children]. Erevan: Aiastan; 1989.]</mixed-citation><mixed-citation xml:lang="en">Аствацатрян ВА, Торосян ЕХ. Периодическая болезнь у детей. Ереван: Айастан; 1989. [Astvatsatryan VA, Torosyan EKh. Periodicheskaya bolezn' u detei [Periodic disease in children]. Erevan: Aiastan; 1989.]</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Akar S, Cetin P, Kalyoncu U. A Nationwide Experience With The Off-label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. Arthritis Care Res (Hoboken). 2017 Oct 9. doi: 10.1002/acr.23446. [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">Akar S, Cetin P, Kalyoncu U. A Nationwide Experience With The Off-label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. Arthritis Care Res (Hoboken). 2017 Oct 9. doi: 10.1002/acr.23446. [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ter Haar N, Lachmann H, Еzen S, et al. Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/ Eurotraps ProjectsTreatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013 May;72(5):678-85. doi: 10.1136/annrheumdis-2011-201268. Epub 2012 Jun 29.</mixed-citation><mixed-citation xml:lang="en">Ter Haar N, Lachmann H, Еzen S, et al. Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/ Eurotraps ProjectsTreatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. 2013 May;72(5):678-85. doi: 10.1136/annrheumdis-2011-201268. Epub 2012 Jun 29.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015 Sep;74(9): 1636-44. doi: 10.1136/annrheumdis-2015-207546. Epub 2015 Jun 24.</mixed-citation><mixed-citation xml:lang="en">Ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015 Sep;74(9): 1636-44. doi: 10.1136/annrheumdis-2015-207546. Epub 2015 Jun 24.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">De Benedetti F, Anton J, Gattorno M, et al. A Phase III, Pivotal, Umbrella Trial of Canakinumab in Patients With Auto-inflammatory Periodic Fever Syndromes (Colchicine- Resistant FMF, HIDS/MKD and TRAPS). Annals of the Rheumatic Diseases. 2016;75:615-6.</mixed-citation><mixed-citation xml:lang="en">De Benedetti F, Anton J, Gattorno M, et al. A Phase III, Pivotal, Umbrella Trial of Canakinumab in Patients With Auto-inflammatory Periodic Fever Syndromes (Colchicine- Resistant FMF, HIDS/MKD and TRAPS). Annals of the Rheumatic Diseases. 2016;75:615-6.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Lachmann H, Simon A, Anton J, et al. FRI0489 Canakinumab Improves Patient Reported Outcomes in Patients with Periodic Fever Syndromes. Annals of the Rheumatic Diseases. 2016;75:616.</mixed-citation><mixed-citation xml:lang="en">Lachmann H, Simon A, Anton J, et al. FRI0489 Canakinumab Improves Patient Reported Outcomes in Patients with Periodic Fever Syndromes. Annals of the Rheumatic Diseases. 2016;75:616.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever. J Nephrol. 2018 Feb 14. doi: 10.1007/s40620- 018-0475-5. [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever. J Nephrol. 2018 Feb 14. doi: 10.1007/s40620- 018-0475-5. [Epub ahead of print].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
